Visit Our Blog
  • FDNA TELEHEALTH
  • Products
    • Face2Gene Labs
    • Face2Gene Clinic
  • About FDNA
  • News & Press
    • In The News
    • Press Releases
  • Contact
  • FDNA Insights

FDNA Insights

Categories
  • All
  • 2018
  • ACMG
  • Case Study
  • Events/Conferences
  • Face2Gene
  • Genomics
  • Pharma
  • Pharma
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos
  • Webinar

AI in Healthcare: Separating the Hype from the Hope

July 9, 2018

By Christen Baglaneas

Events/Conferences,Talks

FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The article below is based on the information he presented at the conference.

By now, AI is so commonplace it’s almost embarrassing if a tech company doesn’t use it. But as much as the sci-fi world likes to pretend otherwise, truly strong general AI is still far away; most AI solutions involve machines programmed for very specific tasks. The most complex systems may conduct many of those tasks, but they’re still not cognitively independent. They still need humans for the most complex problem solving, and nowhere is that more evident than in medicine.

While computers can far outpace humans as processing and analyzing big data, the human touch is still essential to assessing the whole and achieving larger goals. Educating consumers about the line between man and machine is a crucial part of corporate responsibility in the AI space.

Take for example Face2Gene, FDNA’s flagship suite of phenotyping applications. At best, it suggests ideas that never would have occurred to a clinician. At worst, it can become a crutch. FDNA uses regular “Name This Syndrome” challenges to gamify the use of our tools and to remind users to question AI. Follow your GPS exactly and you might drive straight into a ditch–the same is true for relying too heavily on machine learning in the clinical diagnosis process.

In addition to educating users and consumers about the limits of AI, companies must consider how they can influence society. Will AI be only a tool for the wealthy, the white, and the west? Or can AI level the playing field?

The “garbage in, garbage out” premise applies to inequality as well. “Disparities in, disparities out,” we could say of AI data inputs and resulting analyses. (It’s hard to forget the stories of AI bots or algorithms becoming racist or disturbingly morbid after learning from the masses on Twitter and Reddit.)

In the genomics world, the majority of data comes from patients of European descent. To combat that uneven distribution of data, FDNA has worked diligently to create a global network of users and sites in over 130 countries. We have both a free tool and software as a service. Four years after our product launch, more than 50 percent of the patient data contributed is non-Caucasian. Any AI platform is only as good as what it’s being trained on, so as you might expect, when we feed the system with more diverse data, it becomes more robust.

Of course, the more data a company or tool touches, the more concern users have regarding privacy. Fortunately for FDNA, a byproduct of computer vision is de-identified photos, so we’re able to share the information from the data without actually sharing the data. This allows us to spread the benefits of our insights while still protecting patient privacy.

We as companies in this space can learn from one another how to best protect and serve our users and customers. Precision medicine may be powered by AI, but the best applications of these tools require man and machine.

More entries about Events/Conferences

Rare Diseases
 

A Rare Disease Day Reflection

Rare diseases affect roughly 30 million Americans, yet only 5 percent of the estimated 7,000 known rare diseases have cures Read more

Events/Conferences
 

What to Do and See at ASHG 2018

San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more

Events/Conferences
 

AI in Healthcare: Separating the Hype from the Hope

FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more

Events/Conferences
 

FDNA and Face2Gene Featured at ESHG

  A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more

Events/Conferences
 

What to Do and See at ESHG

The European Society of Human Genetics (ESHG) 42nd Annual  Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more

Events/Conferences
 

The Road to Precision Medicine: Balancing Ethics and Efficiency

Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit Read more

Pharma
 

FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain

NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City.   Read more

Events/Conferences
 

What to Do and See at ACMG

The American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting 2018 Charlotte Convention Center · Charlotte, North Carolina · April 10-14, 2018 Read more

Events/Conferences
 

Greenwood Genetic’s Journey: Partnering to Improve Precision Medicine

In its 44 year history, Greenwood Genetic Center (GGC) has seen over 80,000 patient cases. That’s a lot of data. Read more

Events/Conferences
 

Happening at HIMMS: Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey

HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada   As over 40,000 health IT professionals, Read more

Events/Conferences
 

FDNA Announces Genomics Collaborative® at a Global Innovation Summit

English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced Read more

Events/Conferences
 

Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma

In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only Read more

Events/Conferences
 

What to Do and See at ASHG

The American Society of Human Genetics 67th Annual Meeting (ASHG 2017) Orange County Convention Center · Orlando, Florida October 17-21, Read more

Events/Conferences
 

FDNA Presents Rare Disease Technologies at the 2017 Precision Medicine Summit at Boston Children’s Hospital

The Division of Genetics and Genomics Department of Medicine at Boston Children’s Hospital will present their exciting new Fall Precision Read more

Events/Conferences
 

Disorder: The Rare Disease Film Festival

Disorder: The Rare Disease Film Festival will be held October 2 & 3, 2017 in Boston, MA. This is a new event Read more

Events/Conferences
 

What to Do and See at ESHG 2017 in Copenhagen

Annual Clinical Genetics Meeting (ESHG 2017) Bella Center Copenhagen, Copenhagen, Denmark May 27-30, 2017 Copenhagen, Denmark – The time is yet again Read more

Rare Diseases
 

New Facial Analysis Discoveries for RASopathy Syndromes in the Year of Discovery

  In March, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect Read more

Rare Diseases
 

FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery

FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more

Events/Conferences
 

What to Do and See at ACMG 2017 in Phoenix, AZ

Annual Clinical Genetics Meeting (ACMG 2017) Phoenix Convention Center, Phoenix, Arizona March 21-25, 2017 Phoenix, Arizona – With ACMG just over Read more

Rare Diseases
 

FDNA Launches “Year of Discovery” for Rare Disease Day

FDNA Launches “Year of Discovery” for Rare Disease Day Boston-based health and tech start-up calls on patients and clinicians to share Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use

Signup for News


* These fields are required.

© 2011-2021 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.